Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 12.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.75
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 207.19m
  • Volume: 0
  • Market Cap: 25.38m
  • Beta: 0.19

Eden Research Overview

Eden Research is in the pharma and biotech sector and is currently trading at 12.25p per share. In the last year Eden Research's share price has ranged from 7.50p to 15.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -41.5% -29.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 13.5 8.2
Pr/Book 3.0  
Latest F'cast
Revenue 382.1% 64.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Eden Research Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 0.08 (1.63) (1.30)p n/a n/a n/a n/a 0.0%
31-Dec-14 0.10 (3.00) (2.36)p n/a n/a n/a n/a 0.0%
31-Dec-15 0.88 (1.26) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-16 0.39 (1.91) (1.03)p n/a n/a n/a n/a 0.0%
31-Dec-17 1.88 (0.76) (0.33)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Eden Research Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 3.10 (0.90) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-19 4.00 (0.70) (0.30)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Eden Research Company Announcements

Sipcam agreement for Australia and New Zealand 15-Oct-2018 07:00 RNS
Price Monitoring Extension 10-Oct-2018 09:00 RNS
Approval of TerpeneTech head-lice product 10-Oct-2018 07:00 RNS

Latest Eden Research Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Eden Research Market Data

Currency UK Pounds
Share Price 12.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.75
52 Week Low 7.50
Volume 0
Shares Issued 207.19m
Market Cap 25.38m
Beta 0.19

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.4% below the market average22.4% below the market average22.4% below the market average22.4% below the market average22.4% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average
Price Trend
68.20% above the market average68.20% above the market average68.20% above the market average68.20% above the market average68.20% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average
Income Not Available
Growth
69.23% above the market average69.23% above the market average69.23% above the market average69.23% above the market average69.23% above the market average
89.74% above the sector average89.74% above the sector average89.74% above the sector average89.74% above the sector average89.74% above the sector average

Eden Research Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page